A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)
Clinical trial NCT03246529 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03246529
- Sponsor
- BioLineRx, Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-23
- Primary completion
- 2020-12-22
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.